|
|
Volumn 2, Issue 2, 2002, Pages 75-
|
|
Therapeutics: Swinging the vote for rapamycin
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ENDOTHELIAL CELL GROWTH FACTOR;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2;
LYMPHOKINE;
RAPAMYCIN;
SIGNAL PEPTIDE;
VASCULOTROPIN;
VASCULOTROPIN A;
ANIMAL;
ARTICLE;
CELL CULTURE;
CELL DIVISION;
DRUG EFFECT;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
METABOLISM;
METHODOLOGY;
NEOVASCULARIZATION (PATHOLOGY);
ANIMALS;
CELL DIVISION;
ENDOTHELIAL GROWTH FACTORS;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
INTERLEUKIN-2;
LYMPHOKINES;
NEOVASCULARIZATION, PATHOLOGIC;
SIROLIMUS;
TUMOR CELLS, CULTURED;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 84984934487
PISSN: 1474175X
EISSN: 14741768
Source Type: Journal
DOI: 10.1038/nrc739 Document Type: Article |
|
Times cited : (2)
|
|
References (3)
|
